Journals / Turkish Journal of Medical Sciences / 2019 / Cilt: 49 - Sayı: 4

The relationship with clinical course and prognosis of serum endothelin-1, angiopoietin-2, and tie-2 levels in Crimean-Congo hemorrhagic fever

Pages
1192–1197
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

ET-1, Tie-2, and Ang-2 levels are important prognostic parameters in CCHF and may contributesignificantly to treatment and follow-up.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Crimean-Congo hemorrhagic fever (CCHF) is a serious illness characterized by fever and hemorrhage.
📊
Key Findings & Data:Endothelin-1(ET-1), angiopoietin-2 (Ang-2), and endothelial cell-specific receptor tyrosine kinase (Tie-2) are believed to be important markers ofthe pathogenesis, clinical course, and prognosis of the disease.
💡
Conclusion & Impact:ET-1, Tie-2, and Ang-2 levels are important prognostic parameters in CCHF and may contributesignificantly to treatment and follow-up.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Crimean-Congo hemorrhagic fever (CCHF) is a serious illness characterized by fever and hemorrhage. Endothelin-1(ET-1), angiopoietin-2 (Ang-2), and endothelial cell-specific receptor tyrosine kinase (Tie-2) are believed to be important markers ofthe pathogenesis, clinical course, and prognosis of the disease. The aim of this study was to determine ET-1, Ang-2, and Tie-2 levels inadults with CCHF and investigate the associations between these markers and pathogenesis and disease course.Materials and methods: Sixty CCHF patients were included in the study. The patients were classified according to disease severitycriteria and Ang-2, Tie-2, and ET-1 levels were compared.Results: Mean serum ET-1 level was 36.62 ± 27.99 pg/mL in the patient group and 3.70 ± 4.71 pg/mL in the control group (P = 0.001).Mean serum Ang-2 levels were 2511.18 ± 1018.64 pg/mL in the patient group and 3570.76 ± 209.52 pg/mL in the control group (P =0.001). Mean serum Tie-2 levels were 7.35 ± 7.75 ng/mL in the patient group and 0.67 ± 1.26 ng/mL in the control group (P = 0.001).Conclusion: Elevated ET-1 and Tie-2 levels were associated with more severe disease course, while Ang-2 level was negatively correlatedwith severity in adult CCHF patients. ET-1, Tie-2, and Ang-2 levels are important prognostic parameters in CCHF and may contributesignificantly to treatment and follow-up.

🔖

Cite This Article

KERGET, F., ÖZKURT, Z., YILMAZ, S., ÖZTÜRK, N. (2022). The relationship with clinical course and prognosis of serum endothelin-1, angiopoietin-2, and tie-2 levels in Crimean-Congo hemorrhagic fever. Turkish Journal of Medical Sciences, Cilt: 49 - Sayı: 4, 1192–1197. https://ajindex.com/articles/609982

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Nadar SK, Karalis I, Al Yemeni E, Blann AD, Lip GY. Plasma markers of angiogenesis in pregnancy induced hypertension. Thrombosis and Haemostasis 2005
  2. 94 (5): 1071-1076. doi: 10.1160/TH05-03-0167 2. Zwingenberger K, Harms G, Feldmeier H, Müller O, Steiner A et al. Liver involvement in human Schistosomiasis mansoni. Regression of immunological and biochemical disease markers after specific treatment. Acta Tropica 1988
  3. 45 (3): 263-275. 3. Beghetti M, Black SM, Fineman JR. Endothelin-1 in congenital heart disease. Pediatric Research 2005
  4. 16R-20R. doi: 10.1203/01.PDR.0000160447.83332.13 4. Arslan M, Yilmaz G, Mentese A, Yilmaz H, Karahan SC et al. Importance of endothelial dysfunction biomarkers in patients with Crimean‐Congo hemorrhagic fever. Journal of Medical Virology 2017
  5. 89 (12): 2084-2091. doi: 10.1002/jmv.24881 5. Gomes LT, Alves-Junior ER, Rodrigues-Jesus C, Nery AF, Gasquez-Martin TO et al. Angiopoietin-2 and angiopoietin-2/ angiopoietin-1 ratio as indicators of potential severity of Plasmodium vivax malaria in patients with thrombocytopenia. PLoS One 2014
  6. 9 (10): e109246. doi: 10.1371/journal. pone.0109246 6. Sancakdar E, Guven AS, Uysal EB, Deveci K, Gültürk E. Important of angiopoietic system in evaluation of endothelial damage in children with Crimean–Congo hemorrhagic fever. Pediatric Infectious Disease Journal 2015
  7. 34 (8): e200-e205. doi: 10.1097/INF.0000000000000706 7. Ergonul O, Seref C, Eren S, Celikbas A, Baykam N et al. Cytokine response in Crimean‐Congo hemorrhagic fever virus infection. Journal of Medical Virology 2017
  8. 89 (10): 1707- 1713. doi: 10.1002/jmv.24864 8. Swanepoel R, Gill D, Shepherd A, Leman P, Mynhardt J et al. The clinical pathology of Crimean-Congo hemorrhagic fever. Reviews of Infectious Diseases 1989
  9. 11 (Suppl. 4): 794-800. 9. Whitehouse CA. Crimean–Congo hemorrhagic fever. Antiviral Research 2004
  10. 64 (3): 145-160. doi: 10.1016/j. antiviral.2004.08.001 10. Burt FJ, Swanepoel R, Shieh WJ, Smith JF. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Archives of Pathology & Laboratory Medicine 1997
  11. 121 (8): 839. 11. Fisman DN. Hemophagocytic syndromes and infection. Emerging Infectious Diseases 2000
  12. 6 (6): 601. doi: 10.3201/ eid0606.000608 12. Mammen EF. Disseminated intravascular coagulation (DIC). Clinical Laboratory Science 2000
  13. 13 (4): 239. 13. Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA et al. Cr